An outreach strategy in Kenya to vaccinate children against measles in hard-to-reach areas (e.g., beyond 5 km from a vaccination post) would be highly cost-effective, despite the higher cost per child to reach these children. The estimated cost per DALY averted ranged from US$122 (if 50% of these children receive the first dose and one-half of them the second dose) to US$274 (if 100% receive the first dose) — considerably less than the country’s GDP per capita of US$1,865 used as the threshold of cost-effectiveness.
Full Citation:
Lee BY, Brown ST, Haidari LA et al.. 2019. Economic value of vaccinating geographically hard-to-reach populations with measles vaccine: A modeling application in Kenya. Vaccine. 37(17).
Title of Article: Economic value of vaccinating geographically hard-to-reach populations with measles vaccine: A modeling application in Kenya
Author(s): Lee BY, Brown ST, Haidari LA et al.
Publication Year: 2019
Publication Name: Vaccine
Publication Volume: 37(17)
Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/30922700/
DOI (Digital Object Identifier): 10.1016/j.vaccine.2019.03.007
Topics: Economics & Return on Investment
Disease Vaccines: Measles
Immunization Terms: Cost-effectiveness
Countries: Kenya
WHO Regions: Africa